Aeolus Pharmaceuticals Company
Aeolus Pharmaceuticals develops lead compound, AEOL-10150, as a treatment for the pulmonary and delayed effects of acute radiation exposure.
Technology:
undisclosed
Industry:
Small&Large Molecules
Headquarters:
California, United States
Founded Date:
1994
Employees Number:
1-10
Funding Status:
IPO
Register and Claim Ownership